We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Traffic Pollution Exacerbates Symptoms in Asthmatic Children

By HospiMedica International staff writers
Posted on 26 Nov 2008
A new study claims that traffic pollution, especially in cities, adversely affects respiratory health in children with asthma, requiring recurrent additional treatment. More...


Researchers at the Mexican Institute Nacional de Salud Publica (Cuernavaca, Morelos, Mexico) examined 147 asthmatic children and 50 non-asthmatic children (between the ages of 6 and 14) who were followed for 22 weeks to correlate the effect of pollutants with the worsening of respiratory symptoms. The parents kept a daily record of coughing and wheezing experienced by their children, as well as medication usage. Atmospheric levels of the pollutants ozone, nitrogen dioxide, and diesel particles were recorded in Mexico City during the study. The amount and type of traffic in the areas inhabited by the volunteers was also recorded in order to evaluate whether diesel-fuelled vehicles had a greater impact upon respiratory health than pollution from other vehicles.

The study results showed that in the asthmatic children, coughing, wheezing, and medication usage was associated with increased levels of atmospheric pollutants. However, in the healthy volunteers, increased coughing was only seen with higher levels of nitrogen dioxide. Children living in areas with high levels of traffic more often experienced worsening of asthma symptoms and greater use of medication. Small buses for public transport running on petrol or natural gas, and larger buses and trucks running on diesel, were more strongly associated with worsening of symptoms. The study was published in the November 16, 2008, edition of the open access journal Respiratory Research, a publication of BioMed Central,

"Although oxidative stress has been shown to be a major underlying feature of the toxic effect of air pollutants, there is still a need for a better understanding of the actual mechanisms by which pollutants cause exacerbation of respiratory symptoms,” concluded lead author Isabelle Romieu, M.D., MPH, Sc.D. "These results have significant implications for public health policy within cities in Mexico and the rest of the world”.

Related Links:
Institute Nacional de Salud Publica
BioMed Central


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Mammo DR Retrofit Solution
DR Retrofit Mammography
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.